What is Posterior Reversible Encephalopathy Syndrome (PRES)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is PRES Syndrome?

Posterior Reversible Encephalopathy Syndrome (PRES) is a clinical-radiological syndrome characterized by acute neurological symptoms (altered consciousness, seizures, visual disturbances, headaches) and bilateral vasogenic edema predominantly in the parieto-occipital regions on MRI, triggered by conditions that disrupt the blood-brain barrier through endothelial injury. 1

Pathophysiology

The syndrome develops when abrupt blood pressure changes or endothelial toxins cause disruption of the blood-brain barrier, leading to vasogenic edema primarily affecting the posterior brain regions. 1 This occurs when blood pressure is markedly elevated and cerebral autoregulation fails, resulting in cerebral edema in posterior brain areas. 1

Clinical Presentation

Neurological symptoms include: 1, 2

  • Altered consciousness or mental status changes
  • Seizures (common during acute phase, though chronic epilepsy is rare)
  • Visual disturbances including blurred vision or cortical blindness
  • Headaches
  • Focal neurological deficits

The presentation can be heterogeneous, with symptoms ranging from mild to severe. 3

Common Triggering Conditions

The most frequent precipitating factors are: 1, 2, 4

  • Pre-existing arterial hypertension and hypertensive crises
  • Renal impairment or renal failure
  • Eclampsia or pre-eclampsia in pregnant patients
  • Immunosuppressive medications, particularly cyclosporine
  • High-dose chemotherapy or antineoplastic therapy
  • Allogenic stem-cell transplantation or solid organ transplantation
  • Autoimmune diseases
  • Anti-TNF therapy (such as infliximab) 1

Diagnostic Imaging

MRI is the gold standard for diagnosis, showing increased signal intensity on T2-weighted or FLAIR imaging with hyperintensities in bilateral parietal-occipital lobes, predominantly affecting white matter. 1 CT scan can be useful to exclude intracranial hemorrhage when MRI is not immediately feasible. 1

Atypical imaging features can include: 2

  • Involvement of other brain regions beyond parieto-occipital areas
  • Cortical involvement
  • Restricted diffusion
  • Hemorrhage
  • Contrast enhancement

Prognosis and Reversibility

Complete spontaneous remission occurs in most cases without sequelae, making the condition typically reversible with appropriate management. 1 However, early detection and prompt treatment are critical factors for rapid recovery and good outcomes. 1, 4

Factors associated with poor outcomes include: 2

  • Altered sensorium
  • Hypertensive etiology
  • Hyperglycemia
  • Longer time to control the causative factor
  • Elevated C-reactive protein
  • Coagulopathy
  • Extensive cerebral edema
  • Hemorrhage on imaging

While clinical and radiographic reversibility is common, long-standing morbidity and mortality can occur in severe forms, though aggressive care has markedly reduced mortality and improved functional outcomes in malignant forms of PRES. 2

Key Clinical Pitfall

The most critical error is failure to recognize PRES as a potential complication in patients with renal disease, hypertensive crisis, or those receiving immunosuppressive therapy, as delayed recognition can lead to irreversible brain injury despite the typically reversible nature of the syndrome. 3, 4

References

Guideline

Management of Posterior Reversible Encephalopathy Syndrome (PRES)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[PRES (Posterior Reversible Encephalopathy Syndrome): potential complication of hypertensive crisis. Case report and literature review].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.